急性呼吸衰竭。
Acute lung failure.
机构信息
Centre for Infection and Immunity, Queens University Belfast, Belfast, Northern Ireland.
出版信息
Semin Respir Crit Care Med. 2011 Oct;32(5):607-25. doi: 10.1055/s-0031-1287870. Epub 2011 Oct 11.
Abstract
Lung failure is the most common organ failure seen in the intensive care unit. The pathogenesis of acute respiratory failure (ARF) can be classified as (1) neuromuscular in origin, (2) secondary to acute and chronic obstructive airway diseases, (3) alveolar processes such as cardiogenic and noncardiogenic pulmonary edema and pneumonia, and (4) vascular diseases such as acute or chronic pulmonary embolism. This article reviews the more common causes of ARF from each group, including the pathological mechanisms and the principles of critical care management, focusing on the supportive, specific, and adjunctive therapies for each condition.
摘要
肺衰竭是重症监护病房最常见的器官衰竭。急性呼吸衰竭（ARF）的发病机制可分为（1）神经肌肉源性，（2）继发于急性和慢性阻塞性气道疾病，（3）肺泡过程，如心源性和非心源性肺水肿和肺炎，以及（4）血管疾病，如急性或慢性肺栓塞。本文从每组中回顾 ARF 的更常见原因，包括病理机制和重症监护管理原则，重点介绍每种情况的支持、特定和辅助治疗。
相似文献
1
Acute lung failure.急性呼吸衰竭。
Semin Respir Crit Care Med. 2011 Oct;32(5):607-25. doi: 10.1055/s-0031-1287870. Epub 2011 Oct 11.
2
Multi-organ mechanical support for acute respiratory failure with renal failure-Considerations for future research.
Clin Respir J. 2019 Sep;13(9):598-599. doi: 10.1111/crj.13066. Epub 2019 Aug 23.
3
Pathophysiology and Management of Acute Respiratory Distress Syndrome in Children.儿童急性呼吸窘迫综合征的病理生理学与管理
Pediatr Clin North Am. 2017 Oct;64(5):1017-1037. doi: 10.1016/j.pcl.2017.06.004.
4
[Etiology and pathogenesis of acute respiratory failure].
Medicina (Kaunas). 2004;40(3):286-94.
5
Surfactant therapy for acute respiratory distress in children.儿童急性呼吸窘迫综合征的表面活性剂治疗
Acta Biomed. 2013;84 Suppl 1:18-21.
6
Prognostic factors, clinical course, and hospital outcome of patients with chronic obstructive pulmonary disease admitted to an intensive care unit for acute respiratory failure.因急性呼吸衰竭入住重症监护病房的慢性阻塞性肺疾病患者的预后因素、临床病程及住院结局
Crit Care Med. 2002 Jul;30(7):1610-5. doi: 10.1097/00003246-200207000-00035.
7
Acute respiratory failure.急性呼吸衰竭。
Crit Care Clin. 2013 Apr;29(2):167-83. doi: 10.1016/j.ccc.2012.12.004. Epub 2013 Feb 11.
8
Mobile critical care recovery program (m-CCRP) for acute respiratory failure survivors: study protocol for a randomized controlled trial.急性呼吸衰竭幸存者的移动重症监护康复计划（m-CCRP）：一项随机对照试验的研究方案
Trials. 2018 Feb 7;19(1):94. doi: 10.1186/s13063-018-2449-2.
9
The epidemiology of acute respiratory failure in critically ill patients(*).危重症患者急性呼吸衰竭的流行病学（*）
Chest. 2002 May;121(5):1602-9. doi: 10.1378/chest.121.5.1602.
10
Lung Ultrasound for the Diagnosis and Management of Acute Respiratory Failure.肺部超声在急性呼吸衰竭诊断和管理中的应用。
Lung. 2020 Feb;198(1):1-11. doi: 10.1007/s00408-019-00309-1. Epub 2020 Jan 1.
引用本文的文献
1
Mucoactive agent use in adult UK Critical Care Units: a survey of health care professionals' perception, pharmacists' description of practice, and point prevalence of mucoactive use in invasively mechanically ventilated patients.英国成人重症监护病房中黏液促排剂的使用：一项关于医护人员认知、药剂师对实践的描述以及有创机械通气患者黏液促排剂使用现况的调查
PeerJ. 2020 May 4;8:e8828. doi: 10.7717/peerj.8828. eCollection 2020.
2
HIF and HOIL-1L-mediated PKCζ degradation stabilizes plasma membrane Na,K-ATPase to protect against hypoxia-induced lung injury.低氧诱导因子（HIF）和 HOIL-1L 介导的蛋白激酶 Cζ（PKCζ）降解稳定质膜钠钾 ATP 酶，以防止低氧诱导的肺损伤。
Proc Natl Acad Sci U S A. 2017 Nov 21;114(47):E10178-E10186. doi: 10.1073/pnas.1713563114. Epub 2017 Nov 6.
3
High-flow nasal oxygen versus noninvasive ventilation for hypoxemic respiratory failure: Do we know enough?高流量鼻导管吸氧与无创通气治疗低氧性呼吸衰竭：我们了解得够多了吗？
Ann Thorac Med. 2016 Jul-Sep;11(3):163-6. doi: 10.4103/1817-1737.185760.
4
Lung Edema Clearance: Relevance to Patients with Lung Injury.肺水肿清除：与肺损伤患者的相关性。
Rambam Maimonides Med J. 2015 Jul 30;6(3):e0025. doi: 10.5041/RMMJ.10210.
5
Early exercise rehabilitation of muscle weakness in acute respiratory failure patients.急性呼吸衰竭患者肌肉无力的早期运动康复。
Exerc Sport Sci Rev. 2013 Oct;41(4):208-15. doi: 10.1097/JES.0b013e3182a4e67c.
本文引用的文献
1
Inhaled nitric oxide for acute respiratory distress syndrome and acute lung injury in adults and children: a systematic review with meta-analysis and trial sequential analysis.吸入一氧化氮治疗成人和儿童急性呼吸窘迫综合征和急性肺损伤：系统评价与荟萃分析及试验序贯分析。
Anesth Analg. 2011 Jun;112(6):1411-21. doi: 10.1213/ANE.0b013e31820bd185. Epub 2011 Mar 3.
2
3
Diagnosis and management of autoimmune myasthenia gravis.自身免疫性重症肌无力的诊断与治疗。
Clin Drug Investig. 2011;31(1):1-14. doi: 10.2165/11584740-000000000-00000.
4
Effect of oral β-blocker on short and long-term mortality in patients with acute respiratory failure: results from the BASEL-II-ICU study.口服β受体阻滞剂对急性呼吸衰竭患者短期和长期死亡率的影响：来自 BASEL-II-ICU 研究的结果。
Crit Care. 2010;14(6):R198. doi: 10.1186/cc9317. Epub 2010 Nov 3.
5
Genetics of acute lung injury: past, present and future.急性肺损伤的遗传学：过去、现在和未来。
Minerva Anestesiol. 2010 Oct;76(10):860-4. Epub 2010 Jul 1.
6
Therapeutic potential of mesenchymal stem cells for severe acute lung injury.间充质干细胞治疗严重急性肺损伤的潜力。
Chest. 2010 Oct;138(4):965-72. doi: 10.1378/chest.10-0518.
7
Neuromuscular blockers in early acute respiratory distress syndrome.早期急性呼吸窘迫综合征中的神经肌肉阻滞剂。
N Engl J Med. 2010 Sep 16;363(12):1107-16. doi: 10.1056/NEJMoa1005372.
8
Management of submassive pulmonary embolism.亚大面积肺栓塞的管理
Circulation. 2010 Sep 14;122(11):1124-9. doi: 10.1161/CIRCULATIONAHA.110.961136.
9
Acute pulmonary embolism.急性肺栓塞
N Engl J Med. 2010 Jul 15;363(3):266-74. doi: 10.1056/NEJMra0907731. Epub 2010 Jun 30.
10
Intravenous immunoglobulin for Guillain-Barré syndrome.静脉注射免疫球蛋白治疗格林-巴利综合征。
Cochrane Database Syst Rev. 2010 Jun 16(6):CD002063. doi: 10.1002/14651858.CD002063.pub4.
Zotero 插件